Abstract
Exposure to arsenic (As) increases cardiovascular risk. The purpose of this study was to evaluate the relationship between As and intima-media thickness (IMT) in the common carotid artery and common genetic variants in genes implicated in As metabolism (ASIIIMT Met287Thr, GSTT1+/−, and GSTM1+/−) and DNA repair (hOGG1 Ser326Cys and XRCC1 Arg399Ser). Two hundred and fourteen healthy volunteers, age 20–46, were recruited in four zones polluted by As. Urine samples were tested for total As, inorganic As (iAs), monomethylarsinic (MMA), and dimethylarsinic acid (DMA). Primary and secondary methylation index (PMI, SMI) were computed as MMA/iAs and DMA/MMA. Common carotid artery scans were obtained by high-resolution ultrasound. There was no correlation between IMT and total As, iAs, iAs + MMA + DMA, PMI, or SMI. However, the increase of IMT with age was higher than that observed in the healthy population, both in males (6.25 vs. 5.20 μm/year) and, to a lesser extent, in females (5.05 vs. 4.97 μm/year). After correction for age and gender, subjects with a high urinary As level (≥3.86 μg/L) and carriers of the GSTT1-positive (+) genotype also had higher IMT than those with a low urinary level and the GSTT1-null (−) genotype (0.56 [0.48–0.64] vs. 0.53 [0.44–0.62] mm, p = 0.010). The analysis hints at faster vascular aging as compared to the healthy population. Our findings also suggested that GSTT1 and hOGG1 gene polymorphisms might play an important role in the individual risk of As-induced carotid atherosclerosis.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B, Goyer R, Menzer R, Rossman T, Thompson C, Waalkes R (1999) Arsenic: health effects, mechanisms of actions and research issues. Environ Health Perspect 107:593–597
Ameer SS, Engström K, Harari F, Concha G, Vahter M, Broberg K (2015) The effects of arsenic exposure on blood pressure and early markers of cardiovascular disease: evidence for population differences. Environ Res 140:32–36
Andreassi MG, Piccaluga E, Gargani L, Sabatino L, Borghini A, Faita F, Bruno RM, Padovani R, Guagliumi G, Picano E (2015) Subclinical carotid atherosclerosis and early vascular aging from long-term low-dose ionizing radiation exposure: a genetic, telomere, and vascular ultrasound study in cardiac catheterization laboratory staff. Jacc Cardiovasc Interv 8:616–627
Andreassi MG, Foffa I, Manfredi S, Botto N, Cioppa A, Picano E (2009) Genetic polymorphisms in XRCC1, OGG1, APE1 and XRCC3 DNA repair genes, ionizing radiation exposure and chromosomal DNA damage in interventional cardiologists. Mutat Res 666:57–63
Borghini A, Faita F, Mercuri A, Minichilli F, Bustaffa E, Bianchi F, Andreassi MG (2016) Arsenic exposure, genetic susceptibility and leukocyte telomere length in an Italian young adult population. MUTAGENESIS. Epub ahead of print.
Bustaffa E, Bianchi F (2014) Studies on markers of exposure and early effect in areas with arsenic pollution: methods and results of the project SEpiAs. Epidemiological studies on population exposed to low-to-moderate arsenic concentration in drinking water. Epidemiol Prev 38:14–24
Chen Y, Hakim ME, Parvez F, Islam T, Rahman AM, Ahsan H (2006) Arsenic exposure from drinking-water and carotid artery intima-medial thickness in healthy young adults in Bangladesh. J Health Popul Nutr 24:253–257
Chen SC, Chen CC, Kuo CY, Huang CH, Lin CH, Lu ZY, Chen YY, Lee HS, Wong RH (2012) Elevated risk of hypertension induced by arsenic exposure in Taiwanese rural residents: possible effects of manganese superoxide dismutase (MnSOD) and 8-oxoguanine DNA glycosylase (OGG1) genes. Arch Toxicol 86:869–878
Chiou HY, Hsueh YM, Hsieh LL, Hsu LI, Hsu YH, Hsieh FI, Wei ML, Chen HC, Yang HT, Leu LC, Chu TH, Chen-Wu C, Yang MH, Chen CJ (1997) Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res 386:197–207
D’Ippoliti D, Santelli E, De Sario M, Scortichini M, Dacoli M, Michelozzi P (2015) Arsenic in drinking water and mortality for cancer and chronic diseases in Central Italy, 1990-2010. PLoS One 10:e0138182
Durik M, Kavousi M, van der Pluijm I, Isaacs A, Cheng C, Verdonk K, Loot AE, Oeseburg H, Bhaggoe UM, Leijten F, van Veghel R, de Vries R, Rudez G, Brandt R, Ridwan YR, van Deel ED, de Boer M, Tempel D, Fleming I, Mitchell GF, Verwoert GC, Tarasov KV, Uitterlinden AG, Hofman A, Duckers HJ, van Duijn CM, Oostra BA, Witteman JC, Duncker DJ, Danser AH, Hoeijmakers JH, Roks AJ (2012) Nucleotide excision DNA repair is associated with age-related vascular dysfunction. Circulation 126:468–478
Engelen L, Ferreira I, Stehouwer CD, Boutouyrie P, Laurent S (2013) Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur Heart J 34:2368–2380
Faita F, Cori L, Bianchi F, Andreassi MG (2013) Arsenic-induced genotoxicity and genetic susceptibility to arsenic-related pathologies. Int J Environ Res Public Health 10:1527–1546
Faita F, Gemignani V, Bianchini E, Giannarelli C, Ghiadoni L, Demi M (2008) Real-time measurement system for evaluation of the carotid intima-media thickness with a robust edge operator. J Ultrasound Med 27:1353–1361
Farzan SF, Chen Y, Rees JR, Zens MS, Karagas MR (2015) Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study. Toxicol Appl Pharmacol 287:93–97
Garcia-Esquinas E, Pollan M, Umans JG, Francesconi KA, Goessler W, Guallar E, Howard B, Farley J, Best LG, Navas-Acien A (2013) Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study. Cancer Epidemiol Biomark Prev 22:1944–1953
Hays SM, Aylward LL, Gagne M, Nong A, Krishnan K (2010) Biomonitoring equivalents for inorganic arsenic. Regul Toxicol Pharmacol 58:1–9
Hsieh YC, Lien LM, Chung WT, Hsieh FI, Hsieh PF, Wu MM, Tseng HP, Chiou HY, Chen CJ (2011) Significantly increased risk of carotid atherosclerosis with arsenic exposure and polymorphisms in arsenic metabolism genes. Environ Res 111:804–810
Huang YL, Hsueh YM, Huang YK, Yip PK, Yang MH, Chen CJ (2009) Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan. Sci Total Environ 407:2608–2614
Jomova K, Jenisova Z, Feszterova M, Baros S, Liska J, Hudecova D, Rhodes CJ, Valko M (2011) Arsenic: toxicity, oxidative stress and human disease. J Appl Toxicol 31:95–107
Kile ML, Houseman EA, Quamruzzaman Q, Rahman M, Mahiuddin G, Mostofa G, Hsueh YM, Christiani DC (2013) Influence of GSTT1 genetic polymorphisms on arsenic metabolism. J Indian Soc Agric Stat 67:197–207
Leonardi G, Vahter M, Clemens F, Goessler W, Gurzau E, Hemminki K, Hough R, Koppova K, Kumar R, Rudnai P, Surdu S, Fletcher T (2012) Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study. Environ Health Perspect 120:721–726
Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459–467
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31:1281–1357
Manfredi S, Calvi D, del Fiandra M, Botto N, Biagini AMG (2009) Glutathione S-transferase T1- and M1-null genotypes and coronary artery disease risk in patients with type 2 diabetes mellitus. Pharmacogenomics 10:29–34
McCarty KM, Chen YC, Quamruzzaman Q, Rahman M, Mahiuddin G, Hsueh YM, Su L, Smith T, Ryan L, Christiani DC (2007) Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions. Environ Health Perspect 115:341–345
Mendez MA, González-Horta C, Sánchez-Ramírez B, Ballinas-Casarrubias L, Cerón RH, Morales DV, Terrazas FA, Ishida MC, Gutiérrez-Torres DS, Saunders RJ, Drobná Z, Fry RC, Buse JB, Loomis D, García-Vargas GG, Del Razo LM, Stýblo M (2016) Chronic exposure to arsenic and markers of cardiometabolic risk: a cross-sectional study in Chihuahua, Mexico. Environ Health Perspect 124:104–111
Moon KA, Guallar E, Umans JG, Devereux RB, Best LG, Francesconi KA, Goessler W, Pollak J, Silbergeld EK, Howard BV, Navas-Acien A (2013) Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study. Ann Intern Med 159:649–659
Moon K, Guallar E, Navas-Acien A (2012) Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep 14:542–555
Osorio-Yanez C, Ayllon-Vergara JC, Aguilar-Madrid G, Arreola-Mendoza L, Hernandez-Castellanos E, Barrera-Hernandez A, De Vizcaya-Ruiz A, Del Razo LM (2013) Carotid intima-media thickness and plasma asymmetric dimethylarginine in Mexican children exposed to inorganic arsenic. Environ Health Perspect 121:1090–1096
Sidhu MP, Desai KP, Lynch HN, Rhomberg LR, Beck BD, Venditti FJ (2015) Mechanisms of action for arsenic in cardiovascular toxicity and implications for risk assessment. Toxicology 331:78–99
Stea F, Bianchi F, Cori L, Sicari R (2014) Cardiovascular effects of arsenic: clinical and epidemiological findings. Environ Sci Pollut Res Int 21:244–251
Steinmaus C, Ferreccio C, Acevedo J, Yuan Y, Liaw J, Duran V, Cuevas S, Garcia J, Meza R, Valdes R, Valdes G, Benitez H, Vander Linde V, Villagra V, Cantor K, Moore LE, Perez SG, Steinmaus S, Smith AH (2014) Increased lung and bladder cancer incidence in adults after in utero and early-life arsenic exposure. Cancer Epidemiol Biomark Prev 23:1529–1538
Tsuji JS, Perez V, Garry MR, Alexander DD (2014) Association of low-level arsenic exposure in drinking water with cardiovascular disease: a systematic review and risk assessment. Toxicology 323:78–94
Tyler CR, Allan AM (2014) The effects of arsenic exposure on neurological and cognitive dysfunction in human and rodent studies: a review. Curr Environ Health Rep 1:132–147
Wade TJ, Xia Y, Mumford J, Wu K, Le XC, Sams E, Sanders WE (2015) Cardiovascular disease and arsenic exposure in Inner Mongolia, China: a case control study. Environ Health 14:35
Wang CH, Jeng JS, Yip PK, Chen CL, Hsu LI, Hsue YM, Chiou HY, Wu MM, Chen CJ (2002) Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 105:1804–1809
Wang YH, Wu MM, Hong CT, Lien LM, Hsieh YC, Tseng HP, Chang SF, Su CL, Chiou HY, Chen CJ (2007) Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan. Atherosclerosis 192:305–312
WHO-IARC (2012) Arsenic and inorganic arsenic compounds. IARC MONOGRAPHS 100C.
Wu F, Jasmine F, Kibriya MG, Liu M, Cheng X, Parvez F, et al. (2014) Interaction between arsenic exposure from drinking water and genetic susceptibility in carotid intima-media thickness in Bangladesh. Toxicol Appl Pharmacol 276:195–203
Zhong S, Spurr NK, Hayes JD, Wolf CR (1993) Deduced amino acid sequence, gene structure and chromosomal location of a novel human class Mu glutathione S transferase, GSTM4. Biochem J 291:41–50
Acknowledgments
The SepiAs project (Sorveglianza epidemiologica in aree interessate da inquinamento ambientale da arsenico) was funded by the Italian Ministry of Health.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible editor: Philippe Garrigues
Rights and permissions
About this article
Cite this article
Stea, F., Faita, F., Borghini, A. et al. Arsenic and subclinical vascular damage in a sample of Italian young adults: a cross-sectional analysis. Environ Sci Pollut Res 23, 20307–20314 (2016). https://doi.org/10.1007/s11356-016-7260-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-016-7260-6